Search the hub
Showing results for tags 'Europe'.
Found 69 results
-
Content ArticleAll countries of the WHO European Region currently face severe challenges related to the health and care workforce (HCWF). This report focuses on identifying effective policy and planning responses to these HCWF challenges across the Region. The report presents an overview of the HCWF situation in the Region (focusing on medical doctors, nurses, midwives, dentists, pharmacists and physiotherapists, for whom data are available) and identifies relevant policy options, their expected benefits and potential facilitators or barriers to successful implementation. Examples of sound evidence-informed practices in countries are also provided. The aim of the report is to describe the data, rather than to analyse. Data supplied by countries have been used, but in many cases these have been incomplete. It is expected that data will grow progressively in future. No data on informal health workers are included.
-
Content ArticleThe Dutch Hospital Patient Safety Program started in 2008. It initially ran for five years, and its aim was to decrease adverse events by 50% in all Dutch hospitals. A second National Safety Program launched in 2020. This focuses on reflection, interprofessional collaboration and explaining process variation in daily practice. It also looks to foster more patient involvement and shared decision making. The ultimate aim is to reach a significant reduction in preventable patient harm. This webinar provides an overview of patient safety in the Netherlands and discusses these two initiatives and their implementation, outcomes and ongoing impact.
-
News Article
Europe must act now to stop the spread of deadly diseases due to COVID-19
Patient Safety Learning posted a news article in News
Healthcare workers and patients are being put at risk not only from COVID-19 but other deadly diseases as a result of an increase in sharps injuries due to the pandemic. Sharps injuries are accidents where a needle or other medical sharp instrument penetrates the skin with the potential to transfer blood borne viruses, including HIV or hepatitis B or C, from the patient to healthcare worker and vice versa. Sharps injuries cause increased costs and disruption in the healthcare system, which have all been exacerbated by the pandemic anyway. Sharps injuries also have a major emotional and mental impact on staff who always put patients first and literally have put their lives on the line during COVID-19. The European Biosafety Network has commissioned a survey to be published in June on the impact COVID-19 has had on sharps injuries in Europe. The preliminary findings of the survey by Ipsos MORI, covering more than 300,000 healthcare workers in 80 large public hospitals across Europe, show that the number of sharps injuries has increased by some 276,000 injuries (23%) over the last year: with 98% of respondents saying that the increase was a result of the increased pressure and stress due to COVID-19. Other recent published survey results also show that the number of reported sharps injuries has increased as a result of the pandemic. We need to ensure that other existing legislation and regulations which prevent sharps injuries are both understood and complied with. Read full story Source: The Brussels Times, 28 April 2021 -
EventThis webinar from The European Hospital and Healthcare Federation (HOPE) on 29 March at 14:00 BST (15.00 CEST) will look at the Flemish Institute for Quality of Care (VIKZ). VIKZ is a network organisation financed by the Flemish government that has as primary goal to measure, follow up and publicly report quality and safety of care in the Flemish healthcare sector for the purpose of quality improvement. The objectives of the webinar are to: present the methodology used. give an overview of preliminary results. discuss challenges and future objectives of the VIKZ. Speaker Svin Deneckere, director Flemish Institute for Quality of Care (VIKZ) Register
-
EventuntilThe European Alliance for Access to Safe Medicines (EAASM) invites you to join its Parliament roundtable debate entitled “Preventing Medication errors across European hospitals to protect patient safety: Launch of the White Paper on Medication Errors and Traceability” , taking place on 22 March 2022 from 11:30 to 13:30 CET, on Zoom. The EAASM has been coordinating the European Collaborative Action on Medication Errors and Traceability (ECAMET) with the overall objective to markedly reduce medication errors (MEs) at European and national levels, to protect and enhance patient safety and the quality of health care. This event will represent the occasion to officially release a comprehensive White Paper on Medication Errors and Traceability, co-written by the EAASM and the members of the ECAMET Scientific Committee, collecting the results of a pan-European survey on medication errors which acts as a catalyst to understand where improvements can be identified and acted upon, and thus stimulate innovation in the hospital setting via proven digital processes and internal dynamic behavioural changes. Register to attend Please note, this event will take place at 11.30 CET, which is 10.30 GMT
-
Content ArticleThis blog considers the similarities and differences between the Healthcare Safety Investigation Branch in England and Ukom, the Norwegian Healthcare Investigation Board. Both are independent national organisations, which take a no blame approach to patient safety investigations, however they also have a number of distinct differences in their approach.
- Posted
- 1 comment
-
- (and 1 more)
-
Content ArticleMedication errors present a major public health burden and there is a need to optimise risk minimisation and prevention of medication errors through the existing regulatory framework. The European Medicines Agency (EMA) in collaboration with the EU regulatory network was mandated to develop regulatory guidance for medication errors, taking into account the recommendations of a stakeholder workshop held in London in 2013. This guidance is intended to support the implementation of the new legal provisions regarding the reporting, evaluation and prevention of medication errors and is intended mainly for the pharmaceutical industry and national competent authorities. Healthcare professionals (HCP) are expected to consult national clinical guidance on reducing the risk of medication errors.
-
Content ArticleThe subtext of this monthly review of European healthcare issues from Roger Steer is to identify whether Europe can offer lessons to the UK on health and social care issues or indeed how Europe can learn its own lessons and put flesh on the bones of its previous promises of a Social Europe.
-
Content ArticleThis article in DIA Global Forum examines a new collaboration between the European Commission, the European Medicines Agency (EMA) EU Member States Belgium, France, and Germany, the Bill & Melinda Gates Foundation and the recently established African Medicines Agency (AMA). The group will mobilise more than €100 million over the next five years to support the AMA and other African medicines regulatory initiatives at regional and national levels. The initiative will foster collaboration and sharing of technical expertise by European regulators with AMA. It also aims to assist African national regulatory authorities (NRAs) in achieving the minimum World Health Organization (WHO) requirements for effective regulatory oversight of quality-assured, safe, local production of medicines and vaccines.
-
Content ArticleThis analysis from the Health Foundation examines how healthcare spending in the UK compares with EU countries in the decade preceding the pandemic. Taking a longer-term view enables us to see how trends in spending may have impacted healthcare resilience today.
-
Content ArticleWomen are four times as likely to die after childbirth in Britain as in Scandinavian countries, a study published in the BMJ from Diguisto et al. has found. The authors compared maternal mortality in eight countries (France, Italy, UK, Denmark, Finland, the Netherlands, Norway, and Slovakia) with enhanced surveillance systems. They found that UK had the second-highest death rate, with one in 10,000 mothers dying within six weeks of giving birth, only slightly less than in Slovakia, the worst performing. Norway has the lowest maternal death rates in Europe, at one in 37,000. In Denmark, the second-best performing country, one in 29,000 died. In-depth analyses of differences in the quality of care and health system performance at national levels are needed to reduce maternal mortality further by learning from best practices and each other. Cardiovascular diseases and mental health in women during and after pregnancy must be prioritised in all countries.
-
Content ArticleCancer research is a crucial pillar for countries to deliver more affordable, higher quality, and more equitable cancer care. Patients treated in research-active hospitals have better outcomes than patients who are not treated in these settings. However, cancer in Europe is at a crossroads. Cancer was already a leading cause of premature death before the COVID-19 pandemic, and the disastrous effects of the pandemic on early diagnosis and treatment will probably set back cancer outcomes in Europe by almost a decade. Recognising the pivotal importance of research not just to mitigate the pandemic today, but to build better European cancer services and systems for patients tomorrow, the Lancet Oncology European Groundshot Commission on cancer research brings together a wide range of experts, together with detailed new data on cancer research activity across Europe during the past 12 years.
-
Content ArticleThis article in the BMJ highlights a number of recent articles that reflect on the realities facing the health service after the first brutal years of the Covid-19 pandemic. It summarises and links to articles in the BMJ about the elective care backlog, A&E waiting times, remote appointments, Government pressures that stop senior clinicians speaking out about pressures, and the need for credible policy solutions. It also highlights an article outlining how Brexit and the Northern Ireland Protocol have resulted in the UK being denied access to European research funding and meetings.
-
Content ArticleThe last 10 years have seen substantial growth in medical devices that can help people with diabetes to manage their condition, including the development of automated insulin delivery (AID) systems. Regulatory approval has been granted for the first AID systems, and a community of people living with type 1 diabetes has created its own systems using a do-it-yourself approach. This consensus report from the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association offers a review of the current landscape of AID systems and recommends targeted actions.
-
Content ArticleThis dashboard presents the results of a patient safety survey conducted by the European Alliance for Access to Safe Medicines (EAASM) and European Collaborative Action on Medication Errors and Traceability (ECAMET). The dashboard shows variations in different hospital-reported measures of patient safety across thirteen European countries. The questions in the survey focus on accreditation, training, electronic health records and recording, tracking and publishing of medication error data.
-
Content Article
COVID-19: COGER Study (30 November 2020)
Patient Safety Learning posted an article in Data, research and statistics
The COGER study is collecting data to gain insight into the course of functional and medical recovery in older people affected by COVID-19 participating in rehabilitation across Europe. -
Content Article
WHO European non-communicable disease dashboard (January 2022)
Patient-Safety-Learning posted an article in WHO
Non-communicable diseases (NCDs) including cardiovascular disease, cancer, chronic respiratory disease and diabetes, are leading causes of morbidity, disability and mortality in the WHO European Region, causing nearly 90% of all deaths and 67% of premature deaths. The World Health Organization (WHO) Regional Office for Europe has released the WHO Europe NCD Dashboard, which provides graphical data on NCDs in the 53 Member States of the Region and makes comparisons between them. The dashboard enables analysis of a country’s health situation and its progress towards meeting NCD health targets. It includes standardised data from national and international registries and surveys collected by countries, WHO and other international organisations -
Content Article
The Oslo Medicines Initiative
Sam posted an article in Other countries and national agencies
The Oslo Medicines Initiative: “better access to effective, novel, high-priced medicines – a new vision for collaboration between the public and private sectors” is a new initiative of WHO/Europe, developed together with the Norwegian Ministry of Health and Care Services and the Norwegian Medicines Agency. The Initiative will provide a neutral platform for the public and private sectors to jointly outline a vision for equitable and sustainable access to effective, innovative and affordable medicines. -
Content ArticleHappy Patient is a three-year project co-funded by the European Union, that seeks to reduce the impact of antimicrobial resistance (AMR) by decreasing the inappropriate use of antibiotics for the management of common community-acquired infection. Up to 25,000 people die every year in Europe as a direct consequence of the misuse of antibiotics, a figure that rises up to 30,000 in the United States (European Centre for Disease Prevention and Control). The Happy Patient Website offers a variety of communication tools for healthcare professionals and patients, including: Leaflet - Viruses or bacteria: What caused your infection? Urinary tract infections: A leaflet for older adults and their families Antibiotics prescription pad 5 myths about urinary tract infections (UTIs) in nursing home residents What you need to know if you have been prescribed an antibiotic
